Suppr超能文献

人类膀胱移植——现状与未来展望

Urinary bladder transplantation in humans - current status and future perspectives.

作者信息

Czarnogórski Michał C, Koper Krzysztof, Petrasz Piotr, Vetterlein Malte W, Pokrywczyńska Marta, Juszczak Kajetan, Drewa Tomasz, Adamowicz Jan

机构信息

Department and Chair of Urology and Andrology, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Department of Oncology, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

出版信息

Nat Rev Urol. 2025 Mar;22(3):175-186. doi: 10.1038/s41585-024-00935-2. Epub 2024 Sep 20.

Abstract

Urinary bladder vascularized allograft transplantation in humans is currently extensively being investigated worldwide, owing to the theoretical potential of this approach as a therapeutic option for individuals with end-stage, non-oncological bladder conditions or congenital bladder pathologies. To date, a successful attempt at urinary bladder autotransplantation was carried out in a heart-beating brain-dead research human donor. The robot-assisted surgical technique was shown to be optimal for performing this procedure, achieving a good performance in terms of both bladder allograft collection as well as vascular, ureterovesical and vesicourethral anastomoses. The urinary bladder vascularized allograft would be an alternative to traditional urinary diversion methods that rely on the use of intestinal segments, potentially avoiding adverse effects associated with these approaches. However, different from ileal urinary diversion, bladder transplantation would require lifelong immune suppression. Clinical trials are in progress to assess the vascularized bladder allograft transplantation technique, as well as the safety of this procedure in oncological and non-oncological indications.

摘要

由于膀胱血管化同种异体移植理论上有可能成为终末期非肿瘤性膀胱疾病或先天性膀胱病变患者的一种治疗选择,目前全球正在广泛开展相关研究。迄今为止,在一名心脏跳动的脑死亡人类研究供体身上成功进行了膀胱自体移植尝试。结果表明,机器人辅助手术技术最适合实施该手术,在膀胱同种异体移植采集以及血管、输尿管膀胱和膀胱尿道吻合方面均表现良好。膀胱血管化同种异体移植将成为依赖肠段使用的传统尿流改道方法的替代方案,有可能避免与这些方法相关的不良反应。然而,与回肠尿流改道不同,膀胱移植需要终身免疫抑制。目前正在进行临床试验,以评估血管化膀胱同种异体移植技术以及该手术在肿瘤和非肿瘤适应症中的安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验